Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_assertion description "[Taken together, the results from this study indicate that p300 may be a promising molecular therapeutic target through the modulation of cellular sensitivity to doxorubicin in bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_assertion evidence source_evidence_literature NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_assertion SIO_000772 21935574 NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_assertion wasDerivedFrom befree-20140225 NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_assertion wasGeneratedBy ECO_0000203 NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP730354.RABE4mWEszoeB7Qt4GGPUjNTMvfCV9JoAuBhcQNftx-bo130_provenance.